Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Neurol. 2013 Jun 27;260(10):2497–2504. doi: 10.1007/s00415-013-6993-0

Fig 1.

Fig 1

Percentages of enrollees who reported undergoing genetic testing, electromyography testing (EMG), and muscle biopsy. The asterisk (*) indicates a significant difference (2 test) between DM1 and DM2 patients for EMG (p<0.0001), muscle biopsy (p<0.0001) and genetic testing results (p=0.003).